Session Learning Objectives:
1. Understand the importance novel therapies for pediatric pulmonary vascular disease;
2. Understand how to leverage cell- based therapies to improve patient outcomes.

Presenter:
Alexander Holtz, MD, PhD
Instructor in Pediatrics
Division of Genetics and Genomics
Boston Children's Hospital


Dr. Holtz has no relevant financial relationships to disclose.

Session date: 
05/30/2024 - 8:00am to 9:00am EDT
Location: 
Zoom and in person
72 East Concord St.
L112
Boston, MA 02118
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 Participation
Please login or register to take this course.